© IFPMA
Assembling the pharmaceutical R&D puzzle for needs in the developing world
10 May 2012,
The IFPMA launched the report “Assembling the pharmaceutical R&D puzzle for needs in the developing world” from the Pugatch Consilium. The report provides an assessment of new and proposed delinking initiatives aimed at encouraging pharmaceutical R&D into neglected and tropical diseases and specific Type II diseases.
The panel of experts guided the audience through key questions such as: which factors foster R&D on new treatments for diseases disproportionately affecting developing countries? To what extent is boosting R&D on these diseases possible today with the current innovation paradigm? Are there innovative mechanisms to consider? What does delinking mean? Is there a set of criteria for success that policymakers could use to assess new initiatives to boost R&D on these diseases?
20 May 2013, Geneva, Switzerland
The Annual IFPMA Reception on the occasion of the 66th World Health Assembly
UPDATED! Developing World Health Partnerships Directory
The research-based pharmaceutical industry engages in a wide range of public-private partnerships...
IFPMA Code of Practice
Expanded IFPMA Code of Practice updates ethical and professional standards for interacting with...
IFPMA Clinical Trials Portal and Joint Positions on Clinical Trial Results Publication and...
Important online sources of clinical trials information